3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Stomach Neoplasms
1
Rectal Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Neuroblastoma
1
Neoplasm Metastasis
1
Myelodysplastic Syndromes
1
Multiple Myeloma
1
Lymphoma, Non-Hodgkin
1
Leukemia, Myeloid, Acute
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Hodgkin Disease
1
Hematologic Neoplasms
1
Esophageal Neoplasms
1
Colorectal Neoplasms
1
Interventions
Rituximab
46
Cyclophosphamide
38
ibrutinib
23
fludarabine
22
venetoclax
21
acalabrutinib
21
zanubrutinib
17
Lenalidomide
17
Bendamustine Hydrochloride
17
obinutuzumab
16
fludarabine phosphate
14
Magnetic Resonance Spectroscopy
14
Cytarabine
14
Specimen Handling
13
CT-P10
13
pirtobrutinib
12
Biopsy
12
glofitamab
10
Etoposide
10
Whole-Body Irradiation
9
Vincristine
7
Peripheral Blood Stem Cell Transplantation
7
Mycophenolic Acid
7
Melphalan
7
Doxorubicin
7
brexucabtagene autoleucel
6
Cyclosporine
6
orelabrutinib
5
Methotrexate
5
Immunotherapy, Adoptive
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma, Mantle-Cell
×
IL32 protein, human
×
1 year
×
Clear all
No trials found.